Could expanding BRCA gene testing save lives in breast and ovarian cancer?
- Although cancer is not usually inherited, certain types, including breast and ovarian, can be triggered by inherited gene faults, meaning they can run in families. Now that we can test for these mutations, could – and should – we be testing as many people as possible to identify those at higher risk? Isy Godfrey spoke with Beth Torr, Scientific Programme Manager in Cancer Genetics, to find out.
Dr Bernie Croal on prevention and screening
- This October edition of the Bulletin is dedicated primarily to the theme of prevention and screening, interpreted in its broadest sense.
- The issue explores the crucial and multifaceted contributions that pathology makes to preventative healthcare.
- By examining prevention from various perspectives, we aim to highlight how pathology underpins efforts to avert illness, promote public health and support early intervention strategies.
‘A medical miracle’: is period blood ‘the most overlooked opportunity’ in women’s health?
- Period blood has long been thought of as ‘stinky and useless’, but startups are exploring using the fluid to test for a wide range of health conditions – including difficult-to-diagnose endometriosis.
- Innovate UK announces £1.2 million investment in projects aiming to accelerate innovation in digital cognitive assessments for dementia.
- The REAl-world Dementia OUTcomes (READ-OUT) study is a UK research programme aiming to improve early dementia diagnosis by combining blood-based biomarkers with digital cognitive assessments.
- The study, led by the University of Oxford, will involve over 3,000 participants across 28 NHS sites, with a strong focus on inclusion, targeting 30% recruitment from underrepresented groups.
